-
Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z, 2013: Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection[J]. Vaccine, 31, 2215-2221. doi: 10.1016/j.vaccine.2013.03.007
-
Deng CL, Yeo H, Ye HQ, Liu SQ, Shang BD, Gong P, Alonso S, Shi PY, Zhang B, 2014: Inhibition of enterovirus 71 by adenosine analog NITD008[J]. J Virol, 88, 11915-11923. doi: 10.1128/JVI.01207-14
-
Goto K, Sanefuji M, Kusuhara K, Nishimura Y, Shimizu H, Kira R, Torisu H, Hara T, 2009: Rhombencephalitis and coxsackievirus A16[J]. Emerg Infect Dis, 15, 1689-1691. doi: 10.3201/eid1510.090594
-
Han JF, Yu N, Pan YX, He SJ, Xu LJ, Cao RY, Li YX, Zhu SY, Zhang Y, Qin ED, Che XY, Qin CF, 2014: Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice[J]. Virus Res, 179, 212-219. doi: 10.1016/j.virusres.2013.10.020
-
Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, Shiraki K, Kurata T, Takizawa T, 2009: Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007[J]. Jpn J Infect Dis, 62, 254-259.
-
Li W, Yi L, Su J, Lu J, Zeng H, Guan D, Ma C, Zhang W, Xiao H, Li H, Zhang Y, Lin J, Ke C, 2013: Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China[J]. BMC Infect Dis, 13, 322-. doi: 10.1186/1471-2334-13-322
-
Lim XF, Jia Q, Chow VTK, Kwang J, 2013: Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein[J]. J Virol Methods, 188, 76-82. doi: 10.1016/j.jviromet.2012.11.038
-
Man-Li T, Szyporta M, Fang LX, Kwang J, 2012: Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71[J]. J Med Virol, 84, 1620-1627. doi: 10.1002/jmv.v84.10
-
Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J, 2012: A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation[J]. J Virol, 86, 11967-11976. doi: 10.1128/JVI.00902-12
-
Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z, 2013: Coxsackievirus A16: Epidemiology, diagnosis, and vaccine[J]. Hum Vaccin Immunother, 10, 360-367.
-
Oberste MS, Maher K, Kilpatrick DR, Pallansch MA, 1999: Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification[J]. J Virol, 73, 1941-1948.
-
Perera D, Yusof MA, Podin Y, Ooi MH, Thao NT, Wong KK, Zaki A, Chua KB, Malik YA, Tu PV, Tien NT, Puthavathana P, Mc- Minn PC, Cardosa MJ, 2007: Molecular phylogeny of modern coxsackievirus A16[J]. Arch Virol, 152, 1201-1208. doi: 10.1007/s00705-006-0934-5
-
Poyry T, Hyypia T, Horsnell C, Kinnunen L, Hovi T, Stanway G, 1994: Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses[J]. Virology, 202, 982-987. doi: 10.1006/viro.1994.1423
-
Puenpa J, Theamboonlers A, Korkong S, Linsuwanon P, Thongmee C, Chatproedprai S, Poovorawan Y, 2011: Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011[J]. Arch Virol, 156, 2007-2013. doi: 10.1007/s00705-011-1098-5
-
Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B, 2013: Development and characterization of a stable eGFP enterovirus 71 for antiviral screening[J]. Antiviral Res, 97, 198-205. doi: 10.1016/j.antiviral.2012.12.010
-
Shi J, Huang X, Liu Q, Huang Z, 2013: Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16[J]. Vaccine, 31, 2130-2136. doi: 10.1016/j.vaccine.2013.02.051
-
Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM, 2004: Fatal coxsackievirus A16 infection[J]. Pediatr Infect Dis J, 23, 275-276. doi: 10.1097/01.inf.0000115950.63906.78
-
Wei W, Guo H, Li J, Ren S, Wei Z, Bao W, Hu X, Zhao K, Zhang W, Zhou Y, Sun F, Markham R, Yu XF, 2014: Circulating HFMD-associated coxsackievirus A16 is genetically and phenotypically distinct from the prototype CV-A16[J]. PLoS One, 9, e94746-. doi: 10.1371/journal.pone.0094746
-
Xu M, Su L, Cao L, Zhong H, Dong N, Xu J, 2013: Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis[J]. BMC Infect Dis, 13, 489-. doi: 10.1186/1471-2334-13-489
-
Zhang CH, Ma WQ, Yang YL, Wang HM, Dong FT, Huang ZX, 2015: Median effective effect-site concentration of sufentanil for wake-up test in adolescents undergoing surgery: a randomized trial[J]. BMC Anesthesiol, 15, 27-. doi: 10.1186/s12871-015-0003-2
-
Zhang J, Dong M, Jiang B, Dai X, Meng J, 2012: Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71[J]. Virus Res, 167, 337-342. doi: 10.1016/j.virusres.2012.05.019
-
Zhang Y, Wang D, Yan D, Zhu S, Liu J, Wang H, Zhao S, Yu D, Nan L, An J, Chen L, An H, Xu A, Xu W, 2010: Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China[J]. J Clin Microbiol, 48, 619-622. doi: 10.1128/JCM.02338-09
-
Zhou F, Kong F, Wang B, McPhie K, Gilbert GL, Dwyer DE, 2011: Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region[J]. J Med Microbiol, 60, 349-358. doi: 10.1099/jmm.0.025056-0